How DexCom Trounced Wall Street Estimates in Q3
DexCom (NASDAQ: DXCM) rebounded quickly from the coronavirus-fueled market meltdown earlier this year. But while its shares are up more than 70% year to date, the stock has mostly been in a holding pattern in recent months.
The diabetes care technology provider announced its third-quarter results after the market closed on Tuesday. Were those results enough to provide a nice bump for the stock? Here are the highlights from DexCom's Q3 update.
Image source: Getty Images.
Source Fool.com
